LFCR
Lifecore Biomedical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.46
+0.00%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.30
- Revenue estimate
- $25.6M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.19
- EPS estimate
- -$0.19
- Revenue actual
- $34.2M
- Revenue estimate
- $34.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -0.0%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.19 | -$0.19 | In line | $34.2M |
| May 6, 2026 | -$0.29 | -$0.43 | Miss -48.28% | $23.2M |
| Mar 16, 2026 | -$0.29 | -$0.16 | Beat 44.83% | $44.4M |
| Nov 6, 2025 | -$0.30 | -$0.29 | Beat 3.33% | $31.1M |
| Aug 7, 2025 | -$0.09 | -$0.10 | Miss -11.11% | $36.4M |
| Apr 3, 2025 | -$0.14 | -$0.19 | Miss -35.71% | $35.2M |
| Jan 2, 2025 | -$0.27 | -$0.25 | Beat 7.41% | $32.6M |
| Aug 9, 2024 | -$0.12 | -$0.41 | Miss -241.67% | $37.9M |
| May 22, 2024 | -$0.23 | $0.43 | Beat 285.65% | $35.7M |
| Aug 31, 2023 | -$0.07 | -$0.89 | Miss -1171.43% | $24.5M |
| Jun 1, 2023 | -$0.13 | -$0.22 | Miss -69.23% | $31.5M |
| Mar 16, 2023 | -$0.04 | -$0.24 | Miss -500.00% | $21.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026